NULIBRY™ (fosdenopterin)

Approved for Use in the U.S.

Caregivers and healthcare providers, learn more at

Prescribing Information

our products

It is our mission to develop transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Every approved product from BridgeBio represents our commitment to delivering hope through rigorous science.